Emv Capital Plc · LSE:EMVC
Emv Capital — Investor Presentation (December 2025)
27 slides from Emv Capital's investor presentation, Dec 1, 2025
Slide 1: Virtual Meet the Portfolio
DEEP TECH | LIFE SCIENCES | SUSTAINABILITY Virtual Meet the Portfolio Deeptech Recycling Wanda Health 1 December 2025 DEEP TECH | LIFE SCIENCES | SUSTAINABILITY
Slide 2: Disclaimer
DISCLAIMER This presentation (and any information contained in any oral presentation accompanying it) (Presentation) has been prepared by EMV Capital plc (Company). This Presentation has not been approved by an authorised person in accordance with Section 21 of the Financial Services and Markets Act
Slide 3: Introduction to EMV Capital plc
INTRODUCTION TO EMV CAPITAL PLC Vision to be a leading VC Started from £12m AUM investment group in the deep and 8 companies in 2020 tech and life sciences sectors Identifying, investing Over £104m Assets 70 portfolio Building a EMV Capital Partners in, and building high Under Management companies s
Slide 4: Operating Model: Capital Growth
OPERATING MODEL: CAPITAL GROWTH GROW VALUE OF OUR PORTFOLIO COMPANIES VENTURE BUILDING VALUE CREATION SERVICES Selective capital efficient Supporting a cohort of companies balance sheet investment and in protecting value and value in-kind services to capitalise growth upon value opportunities Suppor
Slide 5: EMV Capital Portfolio
EMV CAPITAL PORTFOLIO DEEP TECH, LIFE SCIENCES, SUSTAINABILITY Liver cancer Portfolio of 50+ Medical biomarker, Recycling of plastic Lab technology, Regenerative medicine, Wearable gut monitor, diagnostics, companies managed late clinical waste, industrial pre-sales early clinical early clinical lat
Slide 6: Martlet Capital Portfolio
MARTLET CAPITAL PORTFOLIO DISCRETIONARY FUND MANAGER TO CAMBRIDGE-BASED VC FUND 6 DEEP TECH | LIFE SCIENCES | SUSTAINABILITY STRICTLY PRIVATE
Slide 7: EMVC Venture Build Programme
EMVC VENTURE BUILD PROGRAMME: DRIVING VALUE AND SHAREHOLDER RETURNS Plastic Waste Chemical Recycling Approach ▪ Target IP-rich companies needing strategic direction FV stake increase of £2.5m ▪ Working within large/growing markets 17.5% direct, 27.3% ▪ Restructure via direct equity (cash and/or in-k
Slide 8: Making Plastic a More Sustainable Material
MAKING PLASTIC A MORE SUSTAINABLE MATERIAL Introduction to DeepTech Recycling 01 December 2025 www.deeptech -recycling.co.uk © DeepTech Recycling 2025 – CONFIDENTIAL
Slide 9: The Situation and Problem
1. THE SITUATION AND PROBLEM Plastic demand continues to grow but today’s plastic value chain is linear with minimal recycling 90%+ of current plastic waste is not recycled Global plastic use will continue to skyrocket Global polymer flows in tonnes (OECD 2022 Report) 460 Mt 353 Mt 9% Plastic Plasti
Slide 10: The Market Opportunity
2. THE MARKET OPPORTUNITY Huge opportunity for recycling infrastructure to address the growing global need for sustainable polymer supply Global polymer demand 2030-20401 Projected required investment in (Million metric tonnesper year) advanced recycling infrastructure to satisfy global polymer dema
Slide 11: The Solution – Technology Overview
3. THE SOLUTION – TECHNOLOGY OVERVIEW Chemical recycling is the solution and an emerging sector, delivering the circular economy DeepTech Recycling has one of the leading technologies for chemical recycling of plastic waste A unique Sorting facilities Plastic waste (Non -mechanically DeepTech Recycl
Slide 12: Go-to-Market Strategy
4. GO -TO -MARKET STRATEGY Clear and comprehensive -steps 3 to market leadership Growth 3. Scale-up of operations and global roll-out via licensing / EPC and manufacturing partnerships, strategic collaboration and project / plant sales. Entry into new regional markets, with new facility orders (lice
Slide 13: Commercial Deployment
5. COMMERCIAL DEPLOYMENT Strong pipeline of revenue generating commercial projects progressing quickly to execution exemplified below Project 1(Norway) Project 2(Norway) Project 3(UK) Project 4 £22M project with Norwegian £5M project with established Waste £20M project with leading Project with lead
Slide 14: Projected Financials
6. PROJECTED FINANCIALS Strong revenue growth projections from pipeline Growth / roll-out Underpinned by an efficient and resilient business model phase Projected revenues from current pipeline of projects,c.£1M+ in 2026 . Projected to be cash positive during 2027 and exponential growth thereafter.
Slide 15: The Team
7. TEAM The team Marvine Besong Simon Ashby -Rudd Dr. Ilian Iliev John Clarkson Stephen Crowe Managing Director & CTO Chairman of the Board Investment Director Strategy Director (NED) Interim CFO Marvine has been developing and Simon has extensive experience in the Ilian is the CEO of EMV Capital PL
Slide 16: Thank You
THANK YOU CONTACT US: DeepTech Recycling Origin Building Wootton Science Park Oxfordshire OX13 6FD marvine.besong@dtrecycling.co.uk +44 (0) 1865 602600 www.deeptech -recycling.co.uk 9 9 © DeepTech Recycling © DeepTech 2025Recycling – CONFIDENTIAL. 2025 – CONFIDENTIAL www.deeptech-recycling.co.uk
Slide 17: Intelligent Virtual Care Platform
Intelligent Virtual Care Platform
Slide 18: Intelligent virtual care platform
Intelligent virtual care platform - powered by biometric devices, actionable insights, and dedicated health coaches
Slide 19: Escalating Drug Spend For Payers
Escalating Drug Spend For Payers Health plans are facing unsustainable cost growth driven by chronic disease Rising Medication US Drug Spend $4.5 T GLP-1 Demand Showing Success Dependence Ch ro n ic c o nd it io ns ac c ou nt fo r Paye rs la c k a n inte gr ate d wa y to 7 6 % o f U S A d ul ts ha v
Slide 20: Intelligent Virtual Care Platform
Intelligent Virtual Care Platform Scalable cloud-based Software and Data-as-a-Service for health plans and providers. AI-ready architecture that ingests disease-specific datasets to build predictive and personalised care models. Co-Designed Mobile App - User engagement tools for capturing behavioura
Slide 21: Cardio Metabolic Management Programs
Cardio Metabolic Management Programs Intelligent management for improved adherence, clinical outcomes and ROI Health Plan provides coverage for Cardiometabolic and Data Capture Weight Management Drugs and Associated Programs Biometric, Biomarker, Behavioural and Symptomatic data is captured via Wand
Slide 22: Wanda La Vista Mobile App
Wanda La Vista Mobile App Improving member adherence through engagement Apple and Google Health kit integrations Food Logging with photo capture feature Meal planning, restuarant search and Biometric tabs, charts and notes recommendations Gamification of care plan and progress Personalised daily che
Slide 23: Wanda Insights Engine
Wanda Insights Engine Actionable Intelligence, demonstrable success A unified Reporting and Analytics layer that transforms all platform, device and coaching data into clear, actionable insights. User based reporting for different stakeholders. Individual, program or population level reporting. Medi
Slide 24: Commercial Success
Commercial Success Successfully launched our GLP-1 weight management program. Expanded partnerships with PBMs and multiple health plans. Released our insights engine. Launch of our new cardio metabolic mobile app. Out-competed several billion dollar competitors to win contracts. Exponential double d
Slide 25: Closing Remarks
Closing Remarks Intelligent Virtual Care Platform unifying biometric behavioural and connected device data with a dedicated coaching team. Reshaping Virtual Care - Personalised insights, proactive support and lifestyle change. Best in-class mobile app, Clinical Engagement Portal and Insights Engine.
Slide 26: Any Questions?
(Q Thank you Any Questions?
Slide 27: Join Our Community
JOIN OUR COMMUNITY Follow EMV Capital plc on LinkedIn & Twitter 25-28 Old Burlington Street, London W1S 3AN www.emvcapital.com